Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer
Authors
Keywords
FMISO, Oxygenation, Vascular maturation, Herceptin, BT474, Pimonidazole, Misonidazole
Journal
MOLECULAR IMAGING AND BIOLOGY
Volume 19, Issue 1, Pages 130-137
Publisher
Springer Nature
Online
2016-08-09
DOI
10.1007/s11307-016-0994-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+ breast cancer: preliminary results
- (2016) Anna G. Sorace et al. BREAST CANCER RESEARCH AND TREATMENT
- Monitoring therapeutic efficacy of sunitinib using [18F]FDG and [18F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma
- (2015) Benoît Thézé et al. BMC CANCER
- Dynamic contrast enhanced ultrasound for therapy monitoring
- (2015) John M. Hudson et al. EUROPEAN JOURNAL OF RADIOLOGY
- Multiparametric Magnetic Resonance Imaging for Predicting Pathological Response After the First Cycle of Neoadjuvant Chemotherapy in Breast Cancer
- (2015) Xia Li et al. INVESTIGATIVE RADIOLOGY
- 18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions
- (2015) M. Muzi et al. JOURNAL OF NUCLEAR MEDICINE
- F-18 Fluoromisonidazole for Imaging Tumor Hypoxia: Imaging the Microenvironment for Personalized Cancer Therapy
- (2015) Joseph G. Rajendran et al. SEMINARS IN NUCLEAR MEDICINE
- Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer
- (2015) Nils D. Arvold et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- The accumulation mechanism of the hypoxia imaging probe “FMISO” by imaging mass spectrometry: possible involvement of low-molecular metabolites
- (2015) Yukiko Masaki et al. Scientific Reports
- Noninvasive Multimodality Imaging of the Tumor Microenvironment: Registered Dynamic Magnetic Resonance Imaging and Positron Emission Tomography Studies of a Preclinical Tumor Model of Tumor Hypoxia
- (2015) HyungJoon Cho et al. NEOPLASIA
- The Meaning, Measurement and Modification of Hypoxia in the Laboratory and the Clinic
- (2014) E.M. Hammond et al. CLINICAL ONCOLOGY
- Quantitative multimodality imaging in cancer research and therapy
- (2014) Thomas E. Yankeelov et al. Nature Reviews Clinical Oncology
- Breast cancer as a systemic disease: a view of metastasis
- (2013) A. J. Redig et al. JOURNAL OF INTERNAL MEDICINE
- Potential of PET to Predict the Response to Trastuzumab Treatment in an ErbB2-Positive Human Xenograft Tumor Model
- (2012) G. Kramer-Marek et al. JOURNAL OF NUCLEAR MEDICINE
- Reproducibility of Static and Dynamic 18F-FDG, 18F-FLT, and 18F-FMISO MicroPET Studies in a Murine Model of HER2+ Breast Cancer
- (2012) Jennifer G. Whisenant et al. MOLECULAR IMAGING AND BIOLOGY
- Reducing the toxicity of cancer therapy: recognizing needs, taking action
- (2012) Charles S. Cleeland et al. Nature Reviews Clinical Oncology
- The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy
- (2012) Damien C Weber et al. Radiation Oncology
- 18F-Fluromisonidazole PET Imaging as a Biomarker for the Response to 5,6-Dimethylxanthenone-4-Acetic Acid in Colorectal Xenograft Tumors
- (2011) C. Oehler et al. JOURNAL OF NUCLEAR MEDICINE
- Trastuzumab
- (2011) A. H. Boekhout et al. ONCOLOGIST
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer
- (2009) C. Shah et al. CLINICAL CANCER RESEARCH
- Blood Flow-Metabolism Mismatch: Good for the Tumor, Bad for the Patient
- (2009) D. A. Mankoff et al. CLINICAL CANCER RESEARCH
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
- (2009) R. L. Wahl et al. JOURNAL OF NUCLEAR MEDICINE
- Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors
- (2008) Matthew E. Hardee et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Hypoxia in microscopic tumors
- (2008) Xiao-Feng Li et al. CANCER LETTERS
- New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature
- (2008) Corinne Balleyguier et al. EUROPEAN JOURNAL OF RADIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started